Antibodies News and Research

RSS

Study shows how measles virus causes immune amnesia

Over the last decade, evidence has mounted that the measles vaccine protects in not one but two ways: Not only does it prevent the well-known acute illness with spots and fever that frequently sends children to the hospital, but it also appears to protect from other infections over the long term.

31 Oct 2019

Discovery of 'cellular bike couriers' could shed light on disease spreading mechanisms

A previously unknown component of our cells that delivers proteins like a bike courier in heavy traffic could shed light on the mechanisms that allow cells to spread in diseases such as cancer.

31 Oct 2019

Researchers identify genes linked to most severe symptoms of multiple sclerosis

In a bid to determine factors linked to the most debilitating forms of multiple sclerosis, Johns Hopkins Medicine researchers say they have identified three so-called "complement system" genes that appear to play a role in MS-caused vision loss.

From Johns Hopkins Medicine 31 Oct 2019

Researchers develop new leucocyte markers

An article entitled "Human Peripheral Blood Eosinophils Express High Levels of the Purinergic Receptor P2X4" written by an international immunology research group was recently published in the scientific journal Frontiers in Immunology.

30 Oct 2019

DGIST and Ahn-Gook Pharmaceutical sign R&D agreement for development of anti-cancer antibody

A research group, led by Professor Kyungmoo Yea at the Department of New Biology, DGIST has signed an agreement on the joint R&D for the development of anti-cancer antibody with Ahn-Gook Pharmaceutical Co., Ltd. in September.

30 Oct 2019

Early detection, treatment may reduce risk of death from systemic JIA-associated lung disease

For thousands of children living with the debilitating disease systemic juvenile idiopathic arthritis, a class of medications known as "biologics" have produced dramatic, life-changing improvements.

29 Oct 2019

Femtogenix announces new data on ADCs containing reduced potency payloads in solid tumor models

Femtogenix Ltd, a UK biotechnology company developing the next generation of DNA-interactive Antibody Drug Conjugate payloads, today announced data demonstrating the potent efficacy and favorable toxicity profile of a reduced potency analogue from its Pyridinobenzodiazepine ADC payload platform in solid tumor models.

From Pheon Therapeutics 29 Oct 2019

Novel antibodies could provide a universal flu vaccine

Now, a new study published in the journal Science on October 25, 2019, reports on a set of three novel antibodies that bind to another type of viral cell surface antigen called neuraminidase (NA) that is necessary for viral replication.

28 Oct 2019

Work in progress on medicine for treatment of ulcerative colitis

IKBFU center for clinical research scientists have participated in the international VARSITY clinical research. It's the world's first research aimed at finding the most effective drug among anti-inflammatory ones for the treatment of ulcerative colitis.

28 Oct 2019

New cellular immunotherapy for cancers

A new study published in the journal Nature Communications on 22 October 2019 reports a new approach to cancer treatment that increases the immune capability of T lymphocytes against malignant cancers. This allows the T cells to successfully infiltrate and destroy these tumors. Animal trials have been completed and the researchers are planning clinical trials in human beings next.

26 Oct 2019

Newly identified antibodies could lead to better treatments and vaccines for influenza

A newly identified set of three antibodies could lead to better treatments and vaccines against influenza, according to a paper published this week in Science.

25 Oct 2019

Phase 2 clinical trial of CAR T-cell therapy starts at Atlantic Health System

Atlantic Health System is treating patients in a new Phase 2 clinical trial of CAR T-cell therapy at Morristown Medical Center. A select number of sites across the U.S. are involved in this study, which is done on an outpatient basis.

25 Oct 2019

Researchers find antibody that may protect against wide range of lethal influenza viruses

A nationwide team of researchers has found an antibody that protects mice against a wide range of potentially lethal influenza viruses, advancing efforts to design of a universal vaccine that could either treat or protect people against all strains of the virus.

25 Oct 2019

Scientists make breakthrough in the hunt for new C. diff vaccine

Scientists have made a breakthrough in the hunt for a new vaccine for killer hospital bug Clostridioides difficile (C. diff).

25 Oct 2019

UAB physicians encourage everyone to get a flu shot between October and early November

The change of season in October and November brings in crisp, fall weather for the majority of the United States. Many begin to look toward the holiday season to come, but few think about the impending cold weather and subsequent sickness that pops up when winter arrives.

25 Oct 2019

Flu antibody could be a key to better treatments for severe flu disease

Researchers have found an antibody that protects mice against a wide range of lethal influenza viruses, according to a study from Washington University School of Medicine in St. Louis, Icahn School of Medicine at Mount Sinai in New York City, and Scripps Research in La Jolla, Calif.

24 Oct 2019

Optimal implementation of existing, new interventions essential to end HIV pandemic

Optimal implementation of existing HIV prevention and treatment tools and continued development of new interventions are essential to ending the HIV pandemic, National Institutes of Health experts write in a commentary Clinical Infectious Diseases.

24 Oct 2019

NIAID-supported clinical trial begins at four Vaccine and Treatment Evaluation Units

A clinical trial in which healthy adults will be deliberately infected with influenza virus under carefully controlled conditions is recruiting volunteers at four Vaccine and Treatment Evaluation Units (VTEUs) supported by NIH's National Institute of Allergy and Infectious Diseases.

24 Oct 2019

ConvertibleCAR immunotherapy can be used to attack HIV latent reservoir

A team of Gladstone scientists and their partners at Xyphos Biosciences, Inc. describe a new way of attacking cells infected by HIV in this week's issue of the journal Cell.

24 Oct 2019

Discovery reveals why newer PD-1 targeted therapies sometimes fail

Researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute report a discovery that helps scientists understand why some tumors lack immune cell infiltration and are therefore unresponsive to newer PD-1 targeted therapies.

23 Oct 2019

Antibodies News and Research

Study shows how measles virus causes immune amnesia

Discovery of 'cellular bike couriers' could shed light on disease spreading mechanisms

Researchers identify genes linked to most severe symptoms of multiple sclerosis

Researchers develop new leucocyte markers

DGIST and Ahn-Gook Pharmaceutical sign R&D agreement for development of anti-cancer antibody

Early detection, treatment may reduce risk of death from systemic JIA-associated lung disease

Femtogenix announces new data on ADCs containing reduced potency payloads in solid tumor models

Novel antibodies could provide a universal flu vaccine

Work in progress on medicine for treatment of ulcerative colitis

New cellular immunotherapy for cancers

Newly identified antibodies could lead to better treatments and vaccines for influenza

Phase 2 clinical trial of CAR T-cell therapy starts at Atlantic Health System

Researchers find antibody that may protect against wide range of lethal influenza viruses

Scientists make breakthrough in the hunt for new C. diff vaccine

UAB physicians encourage everyone to get a flu shot between October and early November

Flu antibody could be a key to better treatments for severe flu disease

Optimal implementation of existing, new interventions essential to end HIV pandemic

NIAID-supported clinical trial begins at four Vaccine and Treatment Evaluation Units

ConvertibleCAR immunotherapy can be used to attack HIV latent reservoir

Discovery reveals why newer PD-1 targeted therapies sometimes fail

eBook: End-to-end solutions for bispecific antibody development eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo